Molecular Tumor Pathology
1 – 10 of 25
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
SPATA2 restricts OTULIN-dependent LUBAC activity independently of CYLD
(
- Contribution to journal › Article
-
Mark
PLK1 as a cooperating partner for BCL2-mediated antiapoptotic program in leukemia
(
- Contribution to journal › Article
- 2022
-
Mark
Towards a treatment for mitochondrial disease : current compounds in clinical development
(
- Contribution to journal › Scientific review
-
Mark
The importance of Cyclophilins and Mps1 in cancer
2022)(
- Thesis › Doctoral thesis (compilation)
-
Mark
The role of protein kinases in development and disease
2022) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
The roles of interleukin-1 receptor accessory protein in certain inflammatory conditions
(
- Contribution to journal › Scientific review
-
Mark
Synergistic Effects of Sanglifehrin-Based Cyclophilin Inhibitor NV651 with Cisplatin in Hepatocellular Carcinoma
(
- Contribution to journal › Article
-
Mark
Engineering human mini-bones for the standardized modeling of healthy hematopoiesis, leukemia, and solid tumor metastasis
(
- Contribution to journal › Article
- 2021
-
Mark
Novel Cyclophilin Inhibitor Decreases Cell Proliferation and Tumor Growth in Models of Hepatocellular Carcinoma
(
- Contribution to journal › Article
- 2020
-
Mark
CYLD, a mechanosensitive deubiquitinase, regulates TGFβ signaling in load-induced bone formation
(
- Contribution to journal › Article